Impact of region of interest definition on visual stimulation‐based cerebral vascular reactivity functional MRI with a special focus on applications in cerebral amyloid angiopathy

Cerebral vascular reactivity quantified using blood oxygen level‐dependent functional MRI in conjuncture with a visual stimulus has been proven to be a potent and early marker for cerebral amyloid angiopathy. This work investigates the influence of different postprocessing methods on the outcome of...

Full description

Saved in:
Bibliographic Details
Published inNMR in biomedicine Vol. 36; no. 7; pp. e4916 - n/a
Main Authors Harten, Thijs W., Rooden, Sanneke, Koemans, Emma A., Opstal, Anna M., Greenberg, Steven M., Grond, Jeroen, Wermer, Marieke J. H., Osch, Matthias J. P.
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 01.07.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Cerebral vascular reactivity quantified using blood oxygen level‐dependent functional MRI in conjuncture with a visual stimulus has been proven to be a potent and early marker for cerebral amyloid angiopathy. This work investigates the influence of different postprocessing methods on the outcome of such vascular reactivity measurements. Three methods for defining the region of interest (ROI) over which the reactivity is measured are investigated: structural (transformed V1), functional (template based on the activation of a subset of subjects), and percentile (11.5 cm3 most responding voxels). Evaluation is performed both in a test–retest experiment in healthy volunteers (N = 12), as well as in 27 Dutch‐type cerebral amyloid angiopathy patients and 33 age‐ and sex‐matched control subjects. The results show that the three methods select a different subset of voxels, although all three lead to similar outcome measures in healthy subjects. However, in (severe) pathology, the percentile method leads to higher reactivity measures than the other two, due to circular analysis or “double dipping” by defining a subject‐specific ROI based on the strongest responses within each subject. Furthermore, while different voxels are included in the presence of lesions, this does not necessarily result in different outcome measures. In conclusion, to avoid bias created by the method, either a structural or a functional method is recommended. Both of these methods provide similar reactivity measures, although the functional ROI appears to be less reproducible between studies, because slightly different subsets of voxels were found to be included. On the other hand, the functional method did include fewer lesion voxels than the structural method. In cerebral amyloid angiopathy several postprocessing methods exist to quantify vascular reactivity from visually stimulated BOLD fMRI. In this work three commonly applied methods are investigated.
AbstractList Cerebral vascular reactivity quantified using blood oxygen level‐dependent functional MRI in conjuncture with a visual stimulus has been proven to be a potent and early marker for cerebral amyloid angiopathy. This work investigates the influence of different postprocessing methods on the outcome of such vascular reactivity measurements. Three methods for defining the region of interest (ROI) over which the reactivity is measured are investigated: structural (transformed V1), functional (template based on the activation of a subset of subjects), and percentile (11.5 cm3 most responding voxels). Evaluation is performed both in a test–retest experiment in healthy volunteers (N = 12), as well as in 27 Dutch‐type cerebral amyloid angiopathy patients and 33 age‐ and sex‐matched control subjects. The results show that the three methods select a different subset of voxels, although all three lead to similar outcome measures in healthy subjects. However, in (severe) pathology, the percentile method leads to higher reactivity measures than the other two, due to circular analysis or “double dipping” by defining a subject‐specific ROI based on the strongest responses within each subject. Furthermore, while different voxels are included in the presence of lesions, this does not necessarily result in different outcome measures. In conclusion, to avoid bias created by the method, either a structural or a functional method is recommended. Both of these methods provide similar reactivity measures, although the functional ROI appears to be less reproducible between studies, because slightly different subsets of voxels were found to be included. On the other hand, the functional method did include fewer lesion voxels than the structural method.
Cerebral vascular reactivity quantified using blood oxygen level-dependent functional MRI in conjuncture with a visual stimulus has been proven to be a potent and early marker for cerebral amyloid angiopathy. This work investigates the influence of different postprocessing methods on the outcome of such vascular reactivity measurements. Three methods for defining the region of interest (ROI) over which the reactivity is measured are investigated: structural (transformed V1), functional (template based on the activation of a subset of subjects), and percentile (11.5 cm3 most responding voxels). Evaluation is performed both in a test-retest experiment in healthy volunteers (N = 12), as well as in 27 Dutch-type cerebral amyloid angiopathy patients and 33 age- and sex-matched control subjects. The results show that the three methods select a different subset of voxels, although all three lead to similar outcome measures in healthy subjects. However, in (severe) pathology, the percentile method leads to higher reactivity measures than the other two, due to circular analysis or "double dipping" by defining a subject-specific ROI based on the strongest responses within each subject. Furthermore, while different voxels are included in the presence of lesions, this does not necessarily result in different outcome measures. In conclusion, to avoid bias created by the method, either a structural or a functional method is recommended. Both of these methods provide similar reactivity measures, although the functional ROI appears to be less reproducible between studies, because slightly different subsets of voxels were found to be included. On the other hand, the functional method did include fewer lesion voxels than the structural method.Cerebral vascular reactivity quantified using blood oxygen level-dependent functional MRI in conjuncture with a visual stimulus has been proven to be a potent and early marker for cerebral amyloid angiopathy. This work investigates the influence of different postprocessing methods on the outcome of such vascular reactivity measurements. Three methods for defining the region of interest (ROI) over which the reactivity is measured are investigated: structural (transformed V1), functional (template based on the activation of a subset of subjects), and percentile (11.5 cm3 most responding voxels). Evaluation is performed both in a test-retest experiment in healthy volunteers (N = 12), as well as in 27 Dutch-type cerebral amyloid angiopathy patients and 33 age- and sex-matched control subjects. The results show that the three methods select a different subset of voxels, although all three lead to similar outcome measures in healthy subjects. However, in (severe) pathology, the percentile method leads to higher reactivity measures than the other two, due to circular analysis or "double dipping" by defining a subject-specific ROI based on the strongest responses within each subject. Furthermore, while different voxels are included in the presence of lesions, this does not necessarily result in different outcome measures. In conclusion, to avoid bias created by the method, either a structural or a functional method is recommended. Both of these methods provide similar reactivity measures, although the functional ROI appears to be less reproducible between studies, because slightly different subsets of voxels were found to be included. On the other hand, the functional method did include fewer lesion voxels than the structural method.
Cerebral vascular reactivity quantified using blood oxygen level‐dependent functional MRI in conjuncture with a visual stimulus has been proven to be a potent and early marker for cerebral amyloid angiopathy. This work investigates the influence of different postprocessing methods on the outcome of such vascular reactivity measurements. Three methods for defining the region of interest (ROI) over which the reactivity is measured are investigated: structural (transformed V1), functional (template based on the activation of a subset of subjects), and percentile (11.5 cm 3 most responding voxels). Evaluation is performed both in a test–retest experiment in healthy volunteers (N = 12), as well as in 27 Dutch‐type cerebral amyloid angiopathy patients and 33 age‐ and sex‐matched control subjects. The results show that the three methods select a different subset of voxels, although all three lead to similar outcome measures in healthy subjects. However, in (severe) pathology, the percentile method leads to higher reactivity measures than the other two, due to circular analysis or “double dipping” by defining a subject‐specific ROI based on the strongest responses within each subject. Furthermore, while different voxels are included in the presence of lesions, this does not necessarily result in different outcome measures. In conclusion, to avoid bias created by the method, either a structural or a functional method is recommended. Both of these methods provide similar reactivity measures, although the functional ROI appears to be less reproducible between studies, because slightly different subsets of voxels were found to be included. On the other hand, the functional method did include fewer lesion voxels than the structural method.
Cerebral vascular reactivity quantified using blood oxygen level‐dependent functional MRI in conjuncture with a visual stimulus has been proven to be a potent and early marker for cerebral amyloid angiopathy. This work investigates the influence of different postprocessing methods on the outcome of such vascular reactivity measurements. Three methods for defining the region of interest (ROI) over which the reactivity is measured are investigated: structural (transformed V1), functional (template based on the activation of a subset of subjects), and percentile (11.5 cm3 most responding voxels). Evaluation is performed both in a test–retest experiment in healthy volunteers (N = 12), as well as in 27 Dutch‐type cerebral amyloid angiopathy patients and 33 age‐ and sex‐matched control subjects. The results show that the three methods select a different subset of voxels, although all three lead to similar outcome measures in healthy subjects. However, in (severe) pathology, the percentile method leads to higher reactivity measures than the other two, due to circular analysis or “double dipping” by defining a subject‐specific ROI based on the strongest responses within each subject. Furthermore, while different voxels are included in the presence of lesions, this does not necessarily result in different outcome measures. In conclusion, to avoid bias created by the method, either a structural or a functional method is recommended. Both of these methods provide similar reactivity measures, although the functional ROI appears to be less reproducible between studies, because slightly different subsets of voxels were found to be included. On the other hand, the functional method did include fewer lesion voxels than the structural method. In cerebral amyloid angiopathy several postprocessing methods exist to quantify vascular reactivity from visually stimulated BOLD fMRI. In this work three commonly applied methods are investigated.
Cerebral vascular reactivity quantified using blood oxygen level-dependent functional MRI in conjuncture with a visual stimulus has been proven to be a potent and early marker for cerebral amyloid angiopathy. This work investigates the influence of different postprocessing methods on the outcome of such vascular reactivity measurements. Three methods for defining the region of interest (ROI) over which the reactivity is measured are investigated: structural (transformed V1), functional (template based on the activation of a subset of subjects), and percentile (11.5 cm most responding voxels). Evaluation is performed both in a test-retest experiment in healthy volunteers (N = 12), as well as in 27 Dutch-type cerebral amyloid angiopathy patients and 33 age- and sex-matched control subjects. The results show that the three methods select a different subset of voxels, although all three lead to similar outcome measures in healthy subjects. However, in (severe) pathology, the percentile method leads to higher reactivity measures than the other two, due to circular analysis or "double dipping" by defining a subject-specific ROI based on the strongest responses within each subject. Furthermore, while different voxels are included in the presence of lesions, this does not necessarily result in different outcome measures. In conclusion, to avoid bias created by the method, either a structural or a functional method is recommended. Both of these methods provide similar reactivity measures, although the functional ROI appears to be less reproducible between studies, because slightly different subsets of voxels were found to be included. On the other hand, the functional method did include fewer lesion voxels than the structural method.
Author Grond, Jeroen
Osch, Matthias J. P.
Harten, Thijs W.
Rooden, Sanneke
Opstal, Anna M.
Koemans, Emma A.
Greenberg, Steven M.
Wermer, Marieke J. H.
Author_xml – sequence: 1
  givenname: Thijs W.
  orcidid: 0000-0002-3408-9379
  surname: Harten
  fullname: Harten, Thijs W.
  email: t.w.van_harten@lumc.nl
  organization: Leiden University Medical Center
– sequence: 2
  givenname: Sanneke
  surname: Rooden
  fullname: Rooden, Sanneke
  organization: Leiden University Medical Center
– sequence: 3
  givenname: Emma A.
  surname: Koemans
  fullname: Koemans, Emma A.
  organization: Leiden University Medical Center
– sequence: 4
  givenname: Anna M.
  surname: Opstal
  fullname: Opstal, Anna M.
  organization: Leiden University Medical Center
– sequence: 5
  givenname: Steven M.
  surname: Greenberg
  fullname: Greenberg, Steven M.
  organization: Massachusetts General Hospital
– sequence: 6
  givenname: Jeroen
  surname: Grond
  fullname: Grond, Jeroen
  organization: Leiden University Medical Center
– sequence: 7
  givenname: Marieke J. H.
  surname: Wermer
  fullname: Wermer, Marieke J. H.
  organization: Leiden University Medical Center
– sequence: 8
  givenname: Matthias J. P.
  surname: Osch
  fullname: Osch, Matthias J. P.
  organization: Leiden University Medical Center
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36908068$$D View this record in MEDLINE/PubMed
BookMark eNp1kctu1DAUhi3Uik5LJZ4AWWLDJlNfcrGXUHEZqQUJ0bV14jjUVeIE25kqOx6hL9MX4klwZloqIVjZOufzp-PzH6MDNziD0EtK1pQQdubqfp1LWj5DK0qkzGgu2QFaEVmwjOeCHKHjEG4IISLn7Dk64qUkgpRihe43_Qg64qHF3ny3g1tu1kXjTYi4Ma11Nu7KDm9tmKDDIdp-6mCp_vp5V0MwDdaJr31qbiHo1PTJlrR2a-OM28nphU7ty68bfGvjNQYcRqNtKrWDnsKih3HsrN55QxrhyQn93A22weDSgCPE6_kFOmyhC-b04TxBVx_efzv_lF18-bg5f3uRaS54mdUF6LKmWtaMFUYIoIIwXZWyaXLDaSVaIaFuWCVLWUiecyhawuqihSo3DeT8BL3Ze0c__JjSRlRvgzZdB84MU1CsEmVBKZMyoa__Qm-Gyac_J0qwgpWVKHiiXj1QU92bRo3e9uBn9RhIAtZ7QPshBG9apW3c7SR6sJ2iRC2Jq5S4WhJ_GvHPg0fnP9Bsj97azsz_5dTnd5c7_jfzbr5n
CitedBy_id crossref_primary_10_1177_0271678X231200425
Cites_doi 10.1002/jmri.28194
10.1006/nimg.2002.1132
10.1126/science.aav9518
10.1016/j.nicl.2016.02.020
10.1177/0271678X17691056
10.1109/42.906424
10.1002/ana.22516
10.1097/WCO.0000000000000510
10.1016/j.neuroimage.2009.06.060
10.1006/nimg.2001.0931
10.1016/S1474‐4422(14)70003‐1
10.1002/hbm.23629
10.3389/fphys.2021.643468
10.1002/jmri.28362
10.1002/hbm.10062
10.1016/j.neuroimage.2007.11.059
10.3233/JAD‐210138
10.1161/STROKEAHA.109.554378
10.1097/00004728‐199305000‐00024
10.1016/j.jcm.2016.02.012
10.1002/acn3.574
10.1016/j.neuroimage.2012.01.021
10.1016/S1474‐4422(16)30030‐8
10.1016/j.neuroimage.2003.12.024
10.1093/brain/awx047
10.1016/S1474‐4422(16)30346‐5
10.1016/S1361‐8415(01)00036‐6
10.1212/01.wnl.0000435291.49598.54
10.1111/j.1750‐3639.1996.tb00794.x
10.1177/1747493017730740
10.1161/STROKEAHA.121.035826
10.1212/01.wnl.0000327887.64299.a4
10.1002/hbm.24322
10.17219/acem/114762
10.1109/TMI.2003.822821
10.1212/WNL.56.4.537
10.1002/ana.23566
10.1212/WNL.0000000000200136
10.1111/j.1750‐3639.1996.tb00793.x
10.1212/WNL.0000000000010201
10.1055/s‐0036‐1581993
10.1006/nimg.1999.0516
10.1016/j.neuroimage.2008.09.029
ContentType Journal Article
Copyright 2023 The Authors. published by John Wiley & Sons Ltd.
2023 The Authors. NMR in Biomedicine published by John Wiley & Sons Ltd.
2023. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2023 The Authors. published by John Wiley & Sons Ltd.
– notice: 2023 The Authors. NMR in Biomedicine published by John Wiley & Sons Ltd.
– notice: 2023. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QO
8FD
FR3
K9.
P64
7X8
DOI 10.1002/nbm.4916
DatabaseName Wiley Online Library Open Access (WRLC)
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Biotechnology Research Abstracts
Technology Research Database
Engineering Research Database
ProQuest Health & Medical Complete (Alumni)
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Biotechnology Research Abstracts
Technology Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
CrossRef

MEDLINE
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Physics
EISSN 1099-1492
EndPage n/a
ExternalDocumentID 36908068
10_1002_nbm_4916
NBM4916
Genre article
Journal Article
GrantInformation_xml – fundername: Dutch Research Council (NWO)
  funderid: 14729
– fundername: Dutch Heart Foundation to M.J.H. Wermer
  funderid: 2016T86
– fundername: Dutch Heart Foundation to M.J.H. Wermer
  grantid: 2016T86
– fundername: Dutch Research Council (NWO)
  grantid: 14729
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
123
1L6
1OB
1OC
1ZS
24P
31~
33P
3SF
3WU
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52V
52W
52X
53G
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
DUUFO
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M65
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
P2P
P2W
P2X
P2Z
P4D
PALCI
Q.N
Q11
QB0
QRW
R.K
RGB
RIWAO
RJQFR
ROL
RWI
RX1
SAMSI
SUPJJ
SV3
UB1
V2E
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WXSBR
XG1
XPP
XV2
ZZTAW
~IA
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7QO
8FD
FR3
K9.
P64
7X8
ID FETCH-LOGICAL-c3836-b5ac6b1c9b225e88a1802c769dd4e3178f89abd2796959343a5f02b5fa74eda43
IEDL.DBID DR2
ISSN 0952-3480
1099-1492
IngestDate Fri Jul 11 08:42:58 EDT 2025
Fri Jul 25 10:01:18 EDT 2025
Mon Jul 21 06:06:17 EDT 2025
Tue Jul 01 02:45:47 EDT 2025
Thu Apr 24 23:05:05 EDT 2025
Wed Jan 22 16:20:25 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords functional MRI
postprocessing
cerebral amyloid angiopathy
cerebral vascular reactivity
Language English
License Attribution
2023 The Authors. NMR in Biomedicine published by John Wiley & Sons Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3836-b5ac6b1c9b225e88a1802c769dd4e3178f89abd2796959343a5f02b5fa74eda43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-3408-9379
OpenAccessLink https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fnbm.4916
PMID 36908068
PQID 2825267853
PQPubID 2029982
PageCount 11
ParticipantIDs proquest_miscellaneous_2786511299
proquest_journals_2825267853
pubmed_primary_36908068
crossref_citationtrail_10_1002_nbm_4916
crossref_primary_10_1002_nbm_4916
wiley_primary_10_1002_nbm_4916_NBM4916
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate July 2023
2023-07-00
2023-Jul
20230701
PublicationDateYYYYMMDD 2023-07-01
PublicationDate_xml – month: 07
  year: 2023
  text: July 2023
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Oxford
PublicationTitle NMR in biomedicine
PublicationTitleAlternate NMR Biomed
PublicationYear 2023
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2004; 21
2002; 17
2009; 44
2023; 57
2009; 40
2010
2004; 23
2016; 15
2008; 71
2016; 36
2019; 365
2009; 48
2001; 20
2016; 11
2012; 72
2018; 39
2021; 12
1993; 17
2018; 5
2017; 37
2001; 5
2020; 95
2017; 38
2017; 16
2011; 70
2000; 11
2022; 56
2013; 81
2014; 13
2017; 140
2022; 53
2022; 98
2001; 56
2008; 40
2018; 31
2001; 14
2021; 81
1996; 6
2020; 29
2018; 13
2012; 62
e_1_2_7_6_1
e_1_2_7_5_1
e_1_2_7_4_1
e_1_2_7_3_1
e_1_2_7_9_1
e_1_2_7_8_1
e_1_2_7_7_1
e_1_2_7_19_1
e_1_2_7_18_1
e_1_2_7_17_1
e_1_2_7_16_1
e_1_2_7_40_1
e_1_2_7_2_1
e_1_2_7_15_1
e_1_2_7_41_1
e_1_2_7_14_1
e_1_2_7_42_1
e_1_2_7_13_1
e_1_2_7_43_1
e_1_2_7_12_1
e_1_2_7_44_1
e_1_2_7_11_1
e_1_2_7_45_1
e_1_2_7_10_1
e_1_2_7_26_1
e_1_2_7_27_1
e_1_2_7_28_1
e_1_2_7_29_1
e_1_2_7_30_1
e_1_2_7_25_1
e_1_2_7_31_1
e_1_2_7_24_1
e_1_2_7_32_1
e_1_2_7_23_1
e_1_2_7_33_1
e_1_2_7_22_1
e_1_2_7_34_1
e_1_2_7_21_1
e_1_2_7_35_1
e_1_2_7_20_1
e_1_2_7_36_1
e_1_2_7_37_1
e_1_2_7_38_1
e_1_2_7_39_1
References_xml – volume: 95
  start-page: e1333
  issue: 10
  year: 2020
  end-page: e1340
  article-title: Cerebrovascular reactivity in cerebral amyloid angiopathy, Alzheimer disease, and mild cognitive impairment
  publication-title: Neurology
– volume: 40
  start-page: 644
  issue: 2
  year: 2008
  end-page: 654
  article-title: The respiration response function: the temporal dynamics of fMRI signal fluctuations related to changes in respiration
  publication-title: Neuroimage
– volume: 62
  start-page: 774
  issue: 2
  year: 2012
  end-page: 781
  article-title: FreeSurfer
  publication-title: Neuroimage
– volume: 56
  start-page: 1863
  issue: 6
  year: 2022
  end-page: 1871
  article-title: Cerebrovascular reactivity mapping using resting‐state functional MRI in patients with gliomas
  publication-title: J Magn Reson Imaging
– volume: 31
  start-page: 28
  issue: 1
  year: 2018
  end-page: 35
  article-title: The growing clinical spectrum of cerebral amyloid angiopathy
  publication-title: Curr Opin Neurol
– volume: 15
  start-page: 155
  issue: 2
  year: 2016
  end-page: 163
  article-title: A guideline of selecting and reporting intraclass correlation coefficients for reliability research
  publication-title: J Chiropr Med
– volume: 29
  start-page: 183
  issue: 2
  year: 2020
  end-page: 188
  article-title: Cerebrovascular reactivity and disease activity in relapsing‐remitting multiple sclerosis
  publication-title: Adv Clin Exp Med
– volume: 98
  start-page: e1716
  issue: 17
  year: 2022
  end-page: e1728
  article-title: Cerebrovascular reactivity across the entire brain in cerebral amyloid angiopathy
  publication-title: Neurology
– volume: 365
  issue: 6450
  year: 2019
  article-title: Amyloid β oligomers constrict human capillaries in Alzheimer's disease via signaling to pericytes
  publication-title: Science
– volume: 38
  start-page: 3723
  issue: 7
  year: 2017
  end-page: 3731
  article-title: Relationship between white matter connectivity loss and cortical thinning in cerebral amyloid angiopathy
  publication-title: Hum Brain Mapp
– volume: 13
  start-page: 195
  issue: 2
  year: 2018
  end-page: 206
  article-title: Cerebrovascular reactivity measurement in cerebral small vessel disease: Rationale and reproducibility of a protocol for MRI acquisition and image processing
  publication-title: Int J Stroke
– volume: 5
  start-page: 143
  issue: 2
  year: 2001
  end-page: 156
  article-title: A global optimisation method for robust affine registration of brain images
  publication-title: Med Image Anal
– volume: 81
  start-page: 1659
  issue: 19
  year: 2013
  end-page: 1665
  article-title: Neurovascular decoupling is associated with severity of cerebral amyloid angiopathy
  publication-title: Neurology
– volume: 72
  start-page: 76
  issue: 1
  year: 2012
  end-page: 81
  article-title: Functional MRI detection of vascular reactivity in cerebral amyloid angiopathy
  publication-title: Ann Neurol
– volume: 13
  start-page: 419
  issue: 4
  year: 2014
  end-page: 428
  article-title: Outcome markers for clinical trials in cerebral amyloid angiopathy
  publication-title: Lancet Neurol
– volume: 17
  start-page: 143
  issue: 3
  year: 2002
  end-page: 155
  article-title: Fast robust automated brain extraction
  publication-title: Hum Brain Mapp
– volume: 14
  start-page: 1370
  issue: 6
  year: 2001
  end-page: 1386
  article-title: Temporal autocorrelation in univariate linear modeling of FMRI data
  publication-title: Neuroimage
– volume: 11
  start-page: 66
  issue: 1
  year: 2000
  end-page: 84
  article-title: Brodmann's areas 17 and 18 brought into stereotaxic space‐where and how variable?
  publication-title: Neuroimage
– volume: 37
  start-page: 3433
  issue: 10
  year: 2017
  end-page: 3445
  article-title: Identification of neurovascular changes associated with cerebral amyloid angiopathy from subject‐specific hemodynamic response functions
  publication-title: J Cereb Blood Flow Metab
– volume: 70
  start-page: 871
  issue: 6
  year: 2011
  end-page: 880
  article-title: Cerebral amyloid angiopathy in the elderly
  publication-title: Ann Neurol
– volume: 6
  start-page: 111
  issue: 2
  year: 1996
  end-page: 114
  article-title: Hereditary cerebral hemorrhage with amyloidosis‐Dutch type (HCHWA‐D): I ‐ a review of clinical, radiologic and genetic aspects
  publication-title: Brain Pathol
– volume: 5
  start-page: 788
  issue: 7
  year: 2018
  end-page: 802
  article-title: Altered dynamics of neurovascular coupling in CADASIL
  publication-title: Ann Clin Transl Neurol
– volume: 17
  start-page: 825
  issue: 2
  year: 2002
  end-page: 841
  article-title: Improved optimization for the robust and accurate linear registration and motion correction of brain images
  publication-title: Neuroimage
– volume: 48
  start-page: 63
  issue: 1
  year: 2009
  end-page: 72
  article-title: Accurate and robust brain image alignment using boundary‐based registration
  publication-title: Neuroimage
– volume: 81
  start-page: 1663
  issue: 4
  year: 2021
  end-page: 1671
  article-title: Cortical thickness and its association with clinical cognitive and neuroimaging markers in cerebral amyloid angiopathy
  publication-title: J Alzheimers Dis
– year: 2010
– volume: 21
  start-page: 1748
  issue: 4
  year: 2004
  end-page: 1761
  article-title: Constrained linear basis sets for HRF modelling using variational Bayes
  publication-title: Neuroimage
– volume: 11
  start-page: 461
  year: 2016
  end-page: 467
  article-title: Longitudinal decrease in blood oxygenation level dependent response in cerebral amyloid angiopathy
  publication-title: NeuroImage Clin
– volume: 16
  start-page: 115
  issue: 2
  year: 2017
  end-page: 122
  article-title: Cerebrovascular function in pre‐symptomatic and symptomatic individuals with hereditary cerebral amyloid angiopathy: a case‐control study
  publication-title: Lancet Neurol
– volume: 56
  start-page: 537
  issue: 4
  year: 2001
  end-page: 539
  article-title: Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria
  publication-title: Neurology
– volume: 23
  start-page: 137
  issue: 2
  year: 2004
  end-page: 152
  article-title: Probabilistic independent component analysis for functional magnetic resonance imaging
  publication-title: IEEE Trans Med Imaging
– volume: 57
  start-page: 909
  issue: 3
  year: 2023
  end-page: 915
  article-title: Aging effect, reproducibility, and test‐retest reliability of a new cerebral amyloid angiopathy MRI severity marker‐cerebrovascular reactivity to visual stimulation
  publication-title: J Magn Reson Imaging
– volume: 6
  start-page: 115
  issue: 2
  year: 1996
  end-page: 120
  article-title: Hereditary cerebral hemorrhage with amyloidosis‐Dutch type (HCHWA‐D): II ‐ a review of histopathological aspects
  publication-title: Brain Pathol
– volume: 71
  start-page: 1424
  issue: 18
  year: 2008
  end-page: 1430
  article-title: Impaired visual evoked flow velocity response in cerebral amyloid angiopathy
  publication-title: Neurology
– volume: 44
  start-page: 857
  issue: 3
  year: 2009
  end-page: 869
  article-title: Influence of heart rate on the BOLD signal: the cardiac response function
  publication-title: Neuroimage
– volume: 12
  year: 2021
  article-title: Cerebrovascular reactivity measurement using magnetic resonance imaging: a systematic review
  publication-title: Front Physiol
– volume: 15
  start-page: 811
  issue: 8
  year: 2016
  end-page: 819
  article-title: Alzheimer's Disease Neuroimaging Initiative (ADNI)Cortical atrophy in patients with cerebral amyloid angiopathy: a case‐control study
  publication-title: Lancet Neurol
– volume: 36
  start-page: 233
  issue: 3
  year: 2016
  end-page: 243
  article-title: Sporadic cerebral amyloid angiopathy: pathophysiology, neuroimaging features, and clinical implications
  publication-title: Semin Neurol
– volume: 17
  start-page: 461
  issue: 3
  year: 1993
  end-page: 470
  article-title: Graphical analysis of MR feature space for measurement of CSF, gray‐matter, and white‐matter volumes
  publication-title: J Comput Assist Tomogr
– volume: 140
  start-page: 1829
  issue: 7
  year: 2017
  end-page: 1850
  article-title: Emerging concepts in sporadic cerebral amyloid angiopathy
  publication-title: Brain
– volume: 53
  start-page: 2006
  issue: 6
  year: 2022
  end-page: 2015
  article-title: Longitudinal progression of magnetic resonance imaging markers and cognition in Dutch‐type hereditary cerebral amyloid angiopathy
  publication-title: Stroke
– volume: 40
  start-page: 3022
  issue: 9
  year: 2009
  end-page: 3027
  article-title: Descriptive analysis of the Boston criteria applied to a Dutch‐type cerebral amyloid angiopathy population
  publication-title: Stroke
– volume: 39
  start-page: 4776
  issue: 12
  year: 2018
  end-page: 4786
  article-title: Structural and functional changes of the visual cortex in early Huntington's disease
  publication-title: Hum Brain Mapp
– volume: 20
  start-page: 45
  issue: 1
  year: 2001
  end-page: 57
  article-title: Segmentation of brain MR images through a hidden Markov random field model and the expectation‐maximization algorithm
  publication-title: IEEE Trans Med Imaging
– ident: e_1_2_7_3_1
  doi: 10.1002/jmri.28194
– ident: e_1_2_7_28_1
  doi: 10.1006/nimg.2002.1132
– ident: e_1_2_7_17_1
  doi: 10.1126/science.aav9518
– ident: e_1_2_7_14_1
  doi: 10.1016/j.nicl.2016.02.020
– ident: e_1_2_7_24_1
  doi: 10.1177/0271678X17691056
– ident: e_1_2_7_26_1
  doi: 10.1109/42.906424
– ident: e_1_2_7_5_1
  doi: 10.1002/ana.22516
– ident: e_1_2_7_12_1
  doi: 10.1097/WCO.0000000000000510
– ident: e_1_2_7_27_1
  doi: 10.1016/j.neuroimage.2009.06.060
– ident: e_1_2_7_33_1
  doi: 10.1006/nimg.2001.0931
– ident: e_1_2_7_25_1
  doi: 10.1016/S1474‐4422(14)70003‐1
– ident: e_1_2_7_13_1
  doi: 10.1002/hbm.23629
– ident: e_1_2_7_21_1
  doi: 10.3389/fphys.2021.643468
– ident: e_1_2_7_19_1
  doi: 10.1002/jmri.28362
– ident: e_1_2_7_31_1
  doi: 10.1002/hbm.10062
– ident: e_1_2_7_40_1
  doi: 10.1016/j.neuroimage.2007.11.059
– ident: e_1_2_7_11_1
  doi: 10.3233/JAD‐210138
– ident: e_1_2_7_9_1
  doi: 10.1161/STROKEAHA.109.554378
– ident: e_1_2_7_38_1
  doi: 10.1097/00004728‐199305000‐00024
– ident: e_1_2_7_39_1
  doi: 10.1016/j.jcm.2016.02.012
– ident: e_1_2_7_45_1
  doi: 10.1002/acn3.574
– ident: e_1_2_7_35_1
  doi: 10.1016/j.neuroimage.2012.01.021
– ident: e_1_2_7_10_1
  doi: 10.1016/S1474‐4422(16)30030‐8
– ident: e_1_2_7_37_1
  doi: 10.1016/j.neuroimage.2003.12.024
– ident: e_1_2_7_7_1
  doi: 10.1093/brain/awx047
– ident: e_1_2_7_18_1
  doi: 10.1016/S1474‐4422(16)30346‐5
– ident: e_1_2_7_29_1
  doi: 10.1016/S1361‐8415(01)00036‐6
– ident: e_1_2_7_23_1
  doi: 10.1212/01.wnl.0000435291.49598.54
– ident: e_1_2_7_43_1
  doi: 10.1111/j.1750‐3639.1996.tb00794.x
– ident: e_1_2_7_30_1
– ident: e_1_2_7_4_1
  doi: 10.1177/1747493017730740
– ident: e_1_2_7_20_1
  doi: 10.1161/STROKEAHA.121.035826
– ident: e_1_2_7_16_1
  doi: 10.1212/01.wnl.0000327887.64299.a4
– ident: e_1_2_7_36_1
  doi: 10.1002/hbm.24322
– ident: e_1_2_7_2_1
  doi: 10.17219/acem/114762
– ident: e_1_2_7_32_1
  doi: 10.1109/TMI.2003.822821
– ident: e_1_2_7_8_1
  doi: 10.1212/WNL.56.4.537
– ident: e_1_2_7_15_1
  doi: 10.1002/ana.23566
– ident: e_1_2_7_22_1
  doi: 10.1212/WNL.0000000000200136
– ident: e_1_2_7_42_1
  doi: 10.1111/j.1750‐3639.1996.tb00793.x
– ident: e_1_2_7_44_1
  doi: 10.1212/WNL.0000000000010201
– ident: e_1_2_7_6_1
  doi: 10.1055/s‐0036‐1581993
– ident: e_1_2_7_34_1
  doi: 10.1006/nimg.1999.0516
– ident: e_1_2_7_41_1
  doi: 10.1016/j.neuroimage.2008.09.029
SSID ssj0008432
Score 2.3916142
Snippet Cerebral vascular reactivity quantified using blood oxygen level‐dependent functional MRI in conjuncture with a visual stimulus has been proven to be a potent...
Cerebral vascular reactivity quantified using blood oxygen level-dependent functional MRI in conjuncture with a visual stimulus has been proven to be a potent...
Cerebral vascular reactivity quantified using blood oxygen level‐dependent functional MRI in conjuncture with a visual stimulus has been proven to be a potent...
Cerebral vascular reactivity quantified using blood oxygen level-dependent functional MRI in conjuncture with a visual stimulus has been proven to be a potent...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e4916
SubjectTerms Amyloid
Biological products
Cardiovascular System - pathology
Cerebral amyloid angiopathy
Cerebral Amyloid Angiopathy - diagnostic imaging
Cerebral Amyloid Angiopathy - pathology
cerebral vascular reactivity
Functional magnetic resonance imaging
functional MRI
Humans
Lesions
Magnetic Resonance Imaging - methods
Methods
Photic Stimulation
postprocessing
Reactive oxygen species
Structure-function relationships
Visual stimuli
Title Impact of region of interest definition on visual stimulation‐based cerebral vascular reactivity functional MRI with a special focus on applications in cerebral amyloid angiopathy
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fnbm.4916
https://www.ncbi.nlm.nih.gov/pubmed/36908068
https://www.proquest.com/docview/2825267853
https://www.proquest.com/docview/2786511299
Volume 36
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fa9UwFD_MwXQvul3_XZ0jA9Gn3l3TNGkedTg24Y4xNhj4UJI0hYv3tsPeCvPJj-CX8Qv5STwnbe82nSBCoYWeJik5OfklOed3AF5K7-i0TEZoHPNIaI520HgVSW29kp6WZBScPDmSB2fiw3ly3nlVUixMyw-x3HCjkRHsNQ1wY-vda6Shdj4SCG7Q_JKrFuGhkyvmqFSE3GQIIHgUi3Tc886O-W7_4c2Z6A94eROthulm_wF87Bvaepl8GjULO3Jff-Nw_L8_2YD7HQplb1u12YQVXw7g3l6f_G0AdyfdmfsA1oKTqKsfwo_DEFLJqoJRPoeqpCfim6D8Hiz3xbQMDmAMry_TusEa0IDMuwRhP799pykzZw7lsbkz1nvBYmkUXkFZLBjNs-32JJucHDLaJmaGUTwoDhRWVK6pqfjr5-7YhKsyzfxyVk1zZkpsIKVbvnwEZ_vvT_cOoi7tQ-RwuSwjmxgn7RunLdoan6aGSOqckjrPhUe4kxapNjbnSktiVRaxSYoxt0lhlPC5EfFjWC2r0j8FpnRhCkQkiILGIrYUhuyVkc7jss0qLobwuleBzHWc6JSaY5a1bM48w77JqG-GsLOUvGh5QG6R2eq1KOssQZ1RbDBHRJDEWMTyNfYmHcyY0lcNyqhUBuCrh_Ck1b5lJbHUCOplOoRXQYf-Wnt29G5C92f_Kvgc1jkittb3eAtWF58b_wIR1sJuwx0ujrfDiPoFY6smxw
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dbtMwFD4aQzBu-CkDCgOMhOAqXUkcO9auYGJqYenFtEm7QIpsx5Eq2gTRBmlc8Qi8zF5oT7JznKTb-JEQUqVU6ontysfHn3_O9wG8FM7SaZkIMDjmAVchxkHtZCCUcVI4WpJRcnI6EaMj_uE4Pl6DnS4XpuGHWG240cjw8ZoGOG1Ib19iDTXzAUd0cw2uk6C3X08dXHBHJdyrkyGECIOIJ8OOeXYYbndvXp2LfgOYV_Gqn3D27sCnrqnNPZPPg3ppBvb7LyyO__lf7sLtFoiyt43n3IM1V_ZgY7fTf-vBzbQ9du_BDX9P1C7uw-nYZ1WyqmAk6VCV9I0oJ0jig-WumJb-DhjDz7fposYaMIbMW42wsx8_adbMmUV7bO-MdRdhsTTKsCAhC0ZTbbNDydKDMaOdYqYZpYTiWGFFZesFFX_56B2bcFGmnp_MqmnOdIkNJMXlk0042nt_uDsKWuWHwOKKWQQm1laYN1YZDDcuSTTx1FkpVJ5zh4gnKRKlTR5KJYhYmUc6LoahiQstucs1jx7AelmV7hEwqQpdIChBIDTkkaFMZCe1sA5XbkaGvA-vOx_IbEuLTuocs6whdA4z7JuM-qYPL1aWXxoqkD_YbHVulLXBYJFRenCIoCCOsIjVz9ibdDajS1fVaCMT4bGv6sPDxv1WlURCIa4XSR9eeSf6a-3Z5F1Kz8f_avgcNkaH6X62P558fAK3QgRwzVXkLVhffq3dUwRcS_PMD6xzsTIqCw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwEB5BEYVLgaXAlgJGQnDKNjiO7RyhZdUFdoUqKlXiENmOI63YTSp2g1ROPAIv0xfqkzCTn23Lj4SQIiVSJrYjj8ef7ZlvAJ5J7-i0TAZoHLNAJBztoPEqkIn1SnpaklFw8ngi9w_F26P4qPWqpFiYhh9iteFGI6O21zTAj7N85wJpqJ0PBIKbq3BNyFCTRu8dnFNHaVEnJ0MEwYNI6LAjng35Tvfl5anoN3x5Ga7W883wFnzqWtq4mXweVEs7cN9-IXH8v1-5DRstDGWvGr25A1d80YMbu132tx6sj9tD9x5cr71E3eIunI7qmEpW5owSOpQFPRHhBCX4YJnPp0XtAcbw-jpdVFgDWpB5myHs7PsPmjMz5lAemztjnRsslkbxFZTGgtFE2-xPsvHBiNE-MTOMAkJxpLC8dNWCir948I5NOC_TzE9m5TRjpsAGUr7lk004HL75uLsftHkfAofrZRnY2DhpX7rEorHxWhtiqXNKJlkmPOIdnevE2IyrRBKtsohMnIfcxrlRwmdGRPdgrSgL_wCYSnKTIyRBGBSKyFIcsldGOo_rNqu46MOLTgVS15KiU26OWdrQOfMU-yalvunD05XkcUME8geZ7U6L0tYULFIKDuYICeIIi1i9xt6kkxlT-LJCGaVljXyTPtxvtG9VSSQTRPVS9-F5rUN_rT2dvB7TfetfBZ_A-oe9Yfp-NHn3EG5yRG-NH_I2rC2_VP4Roq2lfVwPq58_vyjD
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impact+of+region+of+interest+definition+on+visual+stimulation%E2%80%90based+cerebral+vascular+reactivity+functional+MRI+with+a+special+focus+on+applications+in+cerebral+amyloid+angiopathy&rft.jtitle=NMR+in+biomedicine&rft.au=Harten%2C+Thijs+W.&rft.au=Rooden%2C+Sanneke&rft.au=Koemans%2C+Emma+A.&rft.au=Opstal%2C+Anna+M.&rft.date=2023-07-01&rft.issn=0952-3480&rft.eissn=1099-1492&rft.volume=36&rft.issue=7&rft.epage=n%2Fa&rft_id=info:doi/10.1002%2Fnbm.4916&rft.externalDBID=10.1002%252Fnbm.4916&rft.externalDocID=NBM4916
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0952-3480&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0952-3480&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0952-3480&client=summon